FDA highlights ideas to improve time to market

06/4/2007 | Deseret News (Salt Lake City), The

The FDA's Critical Path Initiative aims to speed drugs and medical devices from concept to cure and sees personalized medicine as one way to cut R&D costs and time. "We are on the verge of the most profound transformation in the history of medicine," FDA commissioner Dr. Andrew von Eschenbach said.

View Full Article in:

Deseret News (Salt Lake City), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT